International Eurasian Academy of Sciences, IEAS

Academician

Yue GAO

Profile:

Elected Academician of the International Eurasian Academy of Sciences in 2016, Professor Yue Gao is a distinguished Chinese military pharmacist and pharmacologist whose research has made significant contributions to the pharmacology, toxicology, and safety evaluation of traditional Chinese medicine. Born in December 1963 in Yixing, Jiangsu Province, she received her B.S. from Jiangxi University of Traditional Chinese Medicine (1980–1985), her M.S. in Traditional Chinese Medicine Internal Medicine from Tianjin College of Traditional Chinese Medicine, now Tianjin University of Traditional Chinese Medicine, in 1988, and her Ph.D. in Biochemistry and Molecular Biology from the Military Medical Academy in 2004. She was elected Member of the Chinese Academy of Engineering in November 2025. She currently serves as Director of the Pharmacology and Toxicology Research Laboratory at the Institute of Radiation and Radiation Medicine, Academy of Military Medical Sciences; Director of the Key Laboratory of Military Special-Need Traditional Chinese Medicine and Natural Drug Research; and Director of the Military Special Environment Intelligent Traditional Chinese Medicine Research Laboratory. She is also Chief Scientist of the National Traditional Chinese Medicine Inheritance and Innovation “Hundred-Thousand-Ten Thousand” Talent Project (Qi Huang Project) and Leader of the National Traditional Chinese Medicine Cross-Innovation Team. A recipient of the State Council Special Allowance, she was honoured as a Qi Huang Scholar in 2018 and received the National Outstanding Contribution Award in Traditional Chinese Medicine.

Back to list page →

Professor Gao’s research has focused on preclinical drug evaluation, traditional Chinese medicine pharmacology and toxicology, and the modernisation of traditional Chinese medicine compound prescriptions, with particular emphasis on military pharmacy for special environments. Over more than three decades of research, she has developed a technical framework for the safety evaluation of traditional Chinese medicine encompassing early toxicity prediction, toxic-substance analysis, and investigation of toxicity mechanisms, and established a key technology platform for traditional Chinese medicine safety evaluation that has been adopted by research institutions and pharmaceutical enterprises in China. Her work has addressed cross-tissue and cross-platform toxicogenomic prediction, the localisation and enrichment of trace toxic substances, and the rapid screening of interactions between nuclear receptors and drug-metabolising enzymes, contributing to the resolution of key technical challenges in the safety assessment of traditional Chinese medicine. She has authored more than 121 peer-reviewed publications as corresponding author in journals including Nature Communications, Signal Transduction and Targeted Therapy, and Chemical Engineering Journal, and holds 12 authorised invention patents. Her translational work has resulted in one Category 1.1 innovative drug certificate for military special-need traditional Chinese medicine, one Category 1.2 new drug certificate, and three production approvals. As first completer, she has received the National Science and Technology Progress Award (First Prize) and the National Science and Technology Progress Award (Second Prize). Through leadership of major national research programmes, including major projects of the National Natural Science Foundation of China and National Key Research and Development Programmes, Professor Gao has contributed to connecting traditional Chinese medicine with modern pharmacological and toxicological science, advancing the scientific basis for drug safety evaluation, military medical preparedness, and the modernisation of traditional Chinese medicine.